V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave hasdeveloped a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.

Health Care

Biotechnology

V-Wave

Neal Eigler

Jessica Marie Davis

Arek Dobkowski

Lydia Telep

Werner Hafelfinger

Debbie Deutsch

Lior Rosen

Matt Borenzweig

William T. Abraham

William Hughes

Erez Rozenfeld

The Research and Development team at V-Wave is responsible for innovating and enhancing percutaneous implantable devices aimed at treating Chronic Heart Failure. This team, comprised of experts in engineering and medical science, conducts rigorous research, prototypes new designs, and oversees clinical testing to ensure the safety and efficacy of their interatrial shunt. Their ultimate goal is to advance product development to improve patient outcomes and quality of life.

Research and Development

Clinical Operations

Leadership Team

Finance and Accounting

Research and Development

About

Team members

Other teams at V-Wave

Clinical Operations

Leadership Team

Finance and Accounting